Found 26 matching trials
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML PHASE2 This is a prospective, single-arm, open-label clinical study to evaluate th...
Show More Status
Active Not Recruiting
Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia PHASE2 CLAG-M is an active, well tolerated regimen in acute myelogenous leukemia. ...
Show More Location
Westchester Medical Center/New York Medical College
Learn More & Join Trial
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients โค 60 Years Old PHASE3 The study will include newly-diagnosed AML patients, not suffering acute pr...
Show More Location
Weill Cornell Medicine
Learn More & Join Trial
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure N/A Most of patients with acute myeloid leukemia achieved complete remission (C...
Show More Location
Nanfang Hospital of Southern Medical University
Learn More & Join Trial
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms PHASE1 This phase I/II trial finds the best dose, side effects and how well giving...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage PHASE3 Phase III, multicenter, randomized study with two arms (1:1 ratio) enrollin...
Show More Location
O'Neal Comprehensive Cancer Center
Learn More & Join Trial
Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML) NA A prospective, single-arm, multicenter, exploratory study to evaluate the e...
Show More Location
the First Affiliated Hospital,School of Medicine, Zhejiang University
Learn More & Join Trial
Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (โค60) With Acute Myeloid Leukemia PHASE3 In view of the diversity of the biology of acute myeloid leukemia (AML) the...
Show More Location
Copernicus Memorial Hospital
Learn More & Join Trial
GM-CLAG in Relapsed/Refractory FLT3-mutated AML PHASE1 The purpose of this study is to evaluate the dose-limiting toxicities (DLT)...
Show More Location
University of Kentucky
Learn More & Join Trial
CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML PHASE4 This is a multicenter, prospective, randomized controlled clinical study co...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial